Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.55% Nasdaq Up0.29%

Lexicon Pharmaceuticals, Inc. (LXRX)

-NasdaqGS
1.55 Apr 15, 4:00PM EDT
|After Hours : 1.50 Down 0.05 (3.23%) Apr 15, 7:11PM EDT
Get the big picture on all your investments.
Insider RosterGet Insider Roster for:
Insider Holders*
Individual/EntityMost Recent Trans.Shares Owned as of Trans. Date
AMOUYAL PHILIPPE
Director
Acquisition (Non Open Market)
May 10, 2013
21,865
May 10, 2013
ARTAL INTERNATIONAL S.C.A.
Director
Purchase
Oct 23, 2012
283,154,744

Oct 23, 2012
BARKER SAM L
Director
Acquisition (Non Open Market)
May 10, 2013
121,865
May 10, 2013
DEBBANE RAYMOND
Director
Acquisition (Non Open Market)
May 10, 2013
21,865
May 10, 2013
INVUS, CV
Director
Purchase
Oct 23, 2012
283,154,744

Oct 23, 2012
LAPUERTA PABLO
Officer
Option Exercise
Feb 28, 2014
26,783
Feb 28, 2014
LEFKOWITZ ROBERT J MD
Director
Acquisition (Non Open Market)
May 10, 2013
21,865
May 10, 2013
MAIN ALAN J
Officer
Disposition (Non Open Market)
Feb 28, 2014
146,350
Feb 28, 2014
NIES ALAN S
Director
Acquisition (Non Open Market)
May 10, 2013
26,865
May 10, 2013
PALANTONI FRANK
Director
Acquisition (Non Open Market)
May 10, 2013
21,865
May 10, 2013
SANDS ARTHUR T
Officer
Option Exercise
Feb 28, 2014
1,021,329
Feb 28, 2014
SOBECKI CHRISTOPHER J
Director
Acquisition (Non Open Market)
May 10, 2013
22,865
May 10, 2013
SWAIN JUDITH L
Director
Acquisition (Non Open Market)
May 10, 2013
21,865
May 10, 2013
TESSMER JAMES F
Officer
Disposition (Non Open Market)
Feb 28, 2014
61,641
Feb 28, 2014
WADE JEFFREY L
Officer
Disposition (Non Open Market)
Feb 28, 2014
149,789
Feb 28, 2014
ZAMBROWICZ BRIAN P
Officer
Option Exercise
Feb 28, 2014
278,703
Feb 28, 2014

View Transactions for Insiders & Institutional Holders

 
* Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.